Hudson Edge Investment Partners’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,304
| Closed | -$229K | – | 147 |
|
|
2022
Q3 | $229K | Sell |
4,304
-5,796
| -57% | -$308K | 0.09% | 145 |
|
|
2022
Q2 | $589K | Sell |
10,100
-132
| -1% | -$7.7K | 0.21% | 90 |
|
|
2022
Q1 | $781K | Buy |
10,232
+464
| +5% | +$35.4K | 0.25% | 71 |
|
|
2021
Q4 | $588K | Sell |
9,768
-6,129
| -39% | -$369K | 0.18% | 106 |
|
|
2021
Q3 | $890K | Hold |
15,897
| – | – | 0.29% | 76 |
|
|
2021
Q2 | $965K | Buy |
15,897
+3,518
| +28% | +$214K | 0.31% | 74 |
|
|
2021
Q1 | $868K | Buy |
12,379
+452
| +4% | +$31.7K | 0.29% | 66 |
|
|
2020
Q4 | $714K | Buy |
11,927
+5,637
| +90% | +$337K | 0.25% | 75 |
|
|
2020
Q3 | $378K | Buy |
+6,290
| New | +$378K | 0.15% | 125 |
|